Autoregulation of FGF-2 in cardiac myocytes : effect of FGF-2 and [beta]-adrenergic stimulation on FGF-2 promoter activity in transfected neonatal rat cardiac myocyte cultures and transgenic mice
Year: 2004
Type: dissertation
Abstract: Cardiac disease is the leading cause of death in North America.Although there are plenty of therapies available for suruivors, there is still an increasing need for the prevention (or reduction of severity) of heart attacks (myocardial infarction).fn this context, there are naturally-occurring proteins that have been shown to exhibit cardioprotective properties, such as Fibroblast Growth Factor-2 (FGF-2), which is currently in clinical trials for its angiogenic function, and could be exploited further for its other beneficial properties.FGF-2 is naturally produced in the heart and evidence shows that it is released on a beat-to-beat basis.Clearly, continuous FGF-2 release would require a method for its replacement, and the hypothesis proposed is that FGF-2 can regulate its own synthesis at the transcriptional level.A combination of in vitro and in vivo experiments were used to study the effect of FGF-2 on its own synthesis.Neonatal rat cardiac myocytes were transiently transfected with the firefly luciferase gene under the control of approximately 1000 base pairs (bp; nucleotides -1058/+54) of the rat FGF-2 proximal promoter region (-10SBFGFp.luc)then treated with FGF-2.Conditions, including the dose of FGF-2 to be used and the period of treatment, were established.A significant -2.5-fold increase in FGF-2 promoter activity was observed when compared to vehicle-treated myocytes under basal conditions.A transgenic (TG) mouse expressing the -1058FGFp./ucwas used in an attempt to assess the regulation of FGF-2 promoter activity in vivo.FGF-2 has been reported to be released from cardiac myocytes on contraction.The B-adrenergic agonist, isoproterenol (lsP), is known to increase heart rate and inotropy, and was used to indirectly stimulate an increase in heaft rate in TG mice, and, indirectly, FGF-2 release.lsP treatment significantly increased FGF-2 promoter activity in adult TG mice.However, in vitro, the administration of isoproterenol did not induce an increase in FGF-2 promoter activity in transfected cardiac myocytes.This may reflect, among many things, the diminished extracellular FGF-? stores in vitro when compared to whole heads, and differences in developmental stage.The 1000 bp FGF-2 promoter was truncated to approximately 150 bp (nucleotides -1 101+42), and retested for response to direct administration of FGF-2 in vitro in an attempt to elucidate sequences that may be responsible for FGF-2 autoregulation.Treatment of cardiac myocytes transfected with luciferase under the control of nucleotides -1101+42 (-11OFGFp.luc)showed a significant increase in promoter activity comparable to that of -1O58FGFp./ucafter FGF-2 treatment.This suggests that the -150 bp region contains sufficient sequence information for FGF-2 responsiveness.The sequences within the proximal FGF-2 promoter region are GC-rich and contain multiple sites with the potential for binding transcription factors, including overlapping sites for early growth response-1 (Egr-1)and stimulatory protein-1 (Sp1).The ability of Egr-1 or Sp1 iii important in this whole journey.To Papa and Mama, thanks for all the supportbe it emotional or financial, and for the love and patience!Thanks also for pretending to be interested in science!And last, but certainly not least, to John: thanks for the love and support throughout this process.Thanks for being patient, especially on those day- before-the-deadline days, staying up with me for late-night experiments, and for the boost every time it felt like it was impossible.Thanks for giving me heck every time I doubted myself... you were always the constant positive thing when everything else seemed to go wrong.And thanks for listening to all my detailed scientific descriptions of my project, including all the silly analogies!"You are the bestest!!!"
Source: Mspace (University of Manitoba)
Author: Jimenez, Sarah K.
Institution: University of Manitoba
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W6998853171
